Skip to main content

Table 3 Results from extended complement analyses, Skåne laboratory, Lund University, Sweden

From: The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

Lab Results (Skåne) Unit [ref] \ Day # 1 36
CD46/MCP   5,1 MFI  
Alternative pathway function % [30-113] 16 <1
Complement C3 g/L [0.77-1.38] 0.48  
Complement C3d mg/L [< 5] 19.1  
Factor B concentration % [59-154] 103  
Factor H concentration % [69-154] 25 137
Anti-factor H antibodies U/ml [< 99] < 99 <99
Factor I concentration % [60-152] 74  
  1. Genetic analyses, day 90: Heterozygous variant factor B Gly252Ser (population frequency 2%)
\